Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Teva
Julphar
Novartis
Moodys
Covington
Healthtrust
Citi
Boehringer Ingelheim
Express Scripts

Generated: August 20, 2017

DrugPatentWatch Database Preview

Betaxolol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for betaxolol hydrochloride and what is the scope of betaxolol hydrochloride patent protection?

Betaxolol hydrochloride
is the generic ingredient in six branded drugs marketed by Sanofi Aventis Us, Teligent, Epic Pharma, Novartis Pharms Corp, Apotex Inc, Kvk Tech, Alcon, Akorn, and Wockhardt, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for betaxolol hydrochloride. Nine suppliers are listed for this compound.

Summary for Generic Name: betaxolol hydrochloride

Tradenames:6
Patents:0
Applicants:9
NDAs:11
Drug Master File Entries: see list11
Suppliers / Packagers: see list9
Bulk Api Vendors: see list53
Clinical Trials: see list2,262
Patent Applications: see list1,911
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:betaxolol hydrochloride at DailyMed

Pharmacology for Ingredient: betaxolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon
BETOPTIC
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019270-001Aug 30, 1985ATRXYesYes► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
KERLEDEX
betaxolol hydrochloride; chlorthalidone
TABLET;ORAL019807-001Oct 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Kvk Tech
BETAXOLOL HYDROCHLORIDE
betaxolol hydrochloride
TABLET;ORAL078962-001Jun 27, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Wockhardt
BETAXOLOL HYDROCHLORIDE
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC078694-001Nov 16, 2009ATRXNoNo► Subscribe► Subscribe► Subscribe
Alcon
BETOPTIC PILO
betaxolol hydrochloride; pilocarpine hydrochloride
SUSPENSION/DROPS;OPHTHALMIC020619-001Apr 17, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betaxolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
BETOPTIC S
betaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC019845-001Dec 29, 1989► Subscribe► Subscribe
Alcon
BETOPTIC
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019270-001Aug 30, 1985► Subscribe► Subscribe
Novartis Pharms Corp
BETOPTIC S
betaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC019845-001Dec 29, 1989► Subscribe► Subscribe
Alcon
BETOPTIC
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019270-001Aug 30, 1985► Subscribe► Subscribe
Alcon
BETOPTIC
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019270-001Aug 30, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
McKinsey
Boehringer Ingelheim
Mallinckrodt
Cerilliant
Covington
Moodys
Deloitte
Colorcon
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot